In a groundbreaking revelation, the Global Recombinant Vaccines Industry is gearing up for unprecedented growth, with mature regional markets in North America and Europe emerging as leaders. The stellar performance in these regions can be attributed to the effective presence of leading biopharmaceutical companies equipped with GMP-certified sterile manufacturing facilities. This presence not only ensures …